Post-lactation mammary involution is a homeostatic process requiring epithelial apoptosis and clearance. Given that the deficiency of the extracellular metalloproteinase inhibitor TIMP3 impacts epithelial apoptosis and heightens inflammatory response, we investigated whether TIMP3 regulates these distinct processes during the phases of mammary gland involution in the mouse. Here we show that TIMP3 deficiency leads to TNF dysregulation, earlier caspase activation and onset of mitochondrial apoptosis. This accelerated first phase of involution includes faster loss of initiating signals (STAT3 activation; TGFβ3) concurrent with immediate luminal deconstruction through E-cadherin fragmentation. Epithelial apoptosis is followed by accelerated adipogenesis and a greater macrophage and T-cell infiltration in Timp3？/？ involuting glands. Crossing in Tnf deficiency abrogates caspase 3 activation, but heightens macrophage and T-cell influx into Timp3？/？ glands. The data indicate that TIMP3 differentially impacts apoptosis and inflammatory cell influx, based on involvement of TNF, during the process of mammary involution. An understanding of the molecular factors and wound healing microenvironment of the postpartum mammary gland may have implications for understanding pregnancy-associated breast cancer risk.
References
[1]
Garcia-Suarez O, Perez-Perez M, Germana A, Esteban I, Germana G (2003) Involvement of growth factors in thymic involution. Microsc Res Tech 62: 514–523.
[2]
Kwong J, Choi HL, Huang Y, Chan FL (1999) Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell Tissue Res 298: 123–136.
[3]
Nilsen-Hamilton M, Liu Q, Ryon J, Bendickson L, Lepont P, et al. (2003) Tissue involution and the acute phase response. Ann N Y Acad Sci 995: 94–108.
[4]
Howard BA, Gusterson BA (2000) Human breast development. J Mammary Gland Biol Neoplasia 5: 119–137.
[5]
Green KA, Streuli CH (2004) Apoptosis regulation in the mammary gland. Cell Mol Life Sci 61: 1867–1883.
[6]
Hennighausen L, Robinson GW (2005) Information networks in the mammary gland. Nat Rev Mol Cell Biol 6: 715–725.
[7]
Wiseman BS, Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296: 1046–1049.
[8]
Alexander CM, Selvarajan S, Mudgett J, Werb Z (2001) Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 152: 693–703.
[9]
Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ (2004) Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6: R92–R109.
[10]
Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, et al. (2004) Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6: R75–R91.
[11]
Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, et al. (1996) Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122: 181–193.
[12]
Stein T, Salomonis N, Gusterson BA (2007) Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia 12: 25–35.
[13]
Varela LM, Ip MM (1996) Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. Endocrinology 137: 4915–4924.
[14]
Song J, Sapi E, Brown W, Nilsen J, Tartaro K, et al. (2000) Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 106: 1209–1220.
[15]
Nguyen AV, Pollard JW (2000) Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127: 3107–3118.
[16]
Humphreys RC, Bierie B, Zhao L, Raz R, Levy D, et al. (2002) Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 143: 3641–3650.
[17]
Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, et al. (1999) Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13: 2604–2616.
[18]
Marti A, Ritter PM, Jager R, Lazar H, Baltzer A, et al. (2001) Mouse mammary gland involution is associated with cytochrome c release and caspase activation. Mech Dev 104: 89–98.
[19]
Fata JE, Werb Z, Bissell MJ (2004) Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6: 1–11.
[20]
Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R (1999) Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211: 238–254.
[21]
Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, et al. (2003) Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162: 1123–1133.
[22]
Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, et al. (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125: 681–693.
[23]
Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, et al. (2001) Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 108: 831–841.
[24]
Khokha R, Werb Z (2011) Mammary gland reprogramming: metalloproteinases couple form with function. Cold Spring Harb Perspect Biol 3:
[25]
Talhouk RS, Bissell MJ, Werb Z (1992) Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118: 1271–1282.
[26]
Watson CJ (2009) Immune cell regulators in mouse mammary development and involution. J Anim Sci 87: 35–42.
[27]
O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, et al. (2010) Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 176: 1241–1255.
[28]
Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6: 281–291.
[29]
Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727–740.
[30]
Lyons TR, Schedin PJ, Borges VF (2009) Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 14: 87–98.
[31]
Stensheim H, Moller B, van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27: 45–51.
[32]
Mathelin C, Annane K, Treisser A, Chenard MP, Tomasetto C, et al. (2008) Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 28: 2447–2452.
[33]
Woessner JF Jr (2001) That impish TIMP: the tissue inhibitor of metalloproteinases-3. J Clin Invest 108: 799–800.
[34]
Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, et al. (2004) Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969–977.
[35]
Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, et al. (2005) Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res 97: 380–390.
[36]
Mahmoodi M, Sahebjam S, Smookler D, Khokha R, Mort JS (2005) Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am J Pathol 166: 1733–1740.
[37]
Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, et al. (2006) Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 176: 721–725.
[38]
Amour A, Slocombe PM, Webster A, Butler M, Knight CG, et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39–44.
[39]
Lee MH, Knauper V, Becherer JD, Murphy G (2001) Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase. Biochem Biophys Res Commun 280: 945–950.
[40]
Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, et al. (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267–276.
[41]
Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405–413.
[42]
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489.
[43]
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147–157.
[44]
Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305: 626–629.
[45]
Okada H, Suh WK, Jin J, Woo M, Du C, et al. (2002) Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 22: 3509–3517.
[46]
Zhao L, Melenhorst JJ, Hennighausen L (2002) Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3. Mol Endocrinol 16: 2902–2912.
[47]
Schere-Levy C, Buggiano V, Quaglino A, Gattelli A, Cirio MC, et al. (2003) Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res 282: 35–47.
[48]
Yeh WC, Cao Z, Classon M, McKnight SL (1995) Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168–181.
[49]
Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, et al. (2000) Inhibition of adipogenesis by Wnt signaling. Science 289: 950–953.
[50]
Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, et al. (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114: 111–118.
[51]
Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, et al. (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139: 1861–1872.
[52]
Monks J, Geske FJ, Lehman L, Fadok VA (2002) Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia 7: 163–176.
[53]
Lee CS, McDowell GH, Lascelles AK (1969) The importance of macrophages in the removal of fat from the involuting mammary gland. Res Vet Sci 10: 34–38.
[54]
Hurley WL, Finkelstein E (1986) Bovine leukocytes in mammary secretions during involution: surface protein changes. Am J Vet Res 47: 2418–2422.
[55]
Black RA (2004) TIMP3 checks inflammation. Nat Genet 36: 934–935.
[56]
Tatarczuch L, Philip C, Bischof R, Lee CS (2000) Leucocyte phenotypes in involuting and fully involuted mammary glandular tissues and secretions of sheep. J Anat 196(Pt 3): 313–326.
[57]
Wilson RA, Linn JA, Eberhart RJ (1986) A study of bovine T-cell subsets in the blood and mammary gland secretions during the dry period. Vet Immunol Immunopathol 13: 151–164.
[58]
Murthy A, Defamie V, Smookler DS, Di Grappa MA, Horiuchi K, et al. (2010) Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest 120: 2731–2744.
[59]
Watson CJ (2006) Key stages in mammary gland development - Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 8: 203.
[60]
Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R (2002) E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev 115: 53–62.
[61]
Vallorosi CJ, Day KC, Zhao X, Rashid MG, Rubin MA, et al. (2000) Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem 275: 3328–3334.
[62]
Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, et al. (2001) Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 276: 4972–4980.
[63]
Cruz-Munoz W, Sanchez OH, Di Grappa M, English JL, Hill RP, et al. (2006) Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3(-/-) mice. Oncogene.
[64]
English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, et al. (2006) Individual timp deficiencies differentially impact pro-MMP-2 activaiton. J Biol Chem.
[65]
Atabai K, Fernandez R, Huang X, Ueki I, Kline A, et al. (2005) Mfge8 is critical for mammary gland remodeling during involution. Mol Biol Cell 16: 5528–5537.
[66]
Sandahl M, Hunter DM, Strunk KE, Earp HS, Cook RS (2010) Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev Biol 10: 122.
[67]
Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, et al. (2005) Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 12: 107–114.
[68]
Hanayama R, Nagata S (2005) Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci U S A 102: 16886–16891.
